Atlanta company to study AIDS vaccine on humans
Submitted: Jul 8, 2008 - GeoVax Labs, Inc., an Atlanta-based biotechnology company specializing in prevention and treatment of infectious diseases, said Tuesday it hopes to begin a large human trial of its AIDS vaccine this fall. The Emory University spinoff is seeking approval from the U.S. Food and Drug Administration to start a Phase 2 trial this fall of its human version of its preventative vaccine that has proven…
